## Introduction
The United States House of Representatives has made a significant decision regarding the Anti-CBDC bill and the CLARITY Act. A recent vote led to the reattachment of the Anti-CBDC bill to the CLARITY Act, a move that will impact the upcoming Senate review.
—
### U.S. House Reattaches Anti-CBDC Bill to CLARITY Act Ahead of Senate Review
The United States House of Representatives has taken a procedural step by combining the Anti-CBDC bill with the CLARITY Act before transmitting it to the Senate. This decision follows an earlier choice made by lawmakers in July, where they had linked the Anti-CBDC language to the defense spending bill without merging it with the CLARITY Act.
#### Background
In July, lawmakers decided to include the Anti-CBDC language in the defense spending bill separately from the CLARITY Act. However, the recent vote indicates a change in strategy, as the two bills have now been joined retroactively.
#### Implications for Senate Review
The decision to reattach the Anti-CBDC bill to the CLARITY Act ahead of the Senate review signifies a more consolidated approach by the House of Representatives. This move could have significant implications for the upcoming Senate discussions and decision-making process.
The post **U.S. House Reattaches Anti-CBDC Bill to CLARITY Act Ahead of Senate Review** first appeared on CoinGape.
—
## Conclusion
The recent decision by the U.S. House of Representatives to combine the Anti-CBDC bill with the CLARITY Act reflects important developments in the legislative process. As the bill moves towards Senate review, the implications of this decision remain to be seen. Stay tuned for further updates on this important legislative development.